Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)

Hong Kong · Delayed Price · Currency is HKD

2.345

+0.005 (0.21%)

Aug 26, 2026, 10:08 AM HKT

HKG:8049 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	898.05	901.87	881.16	841.55	841.59	705.46
Revenue Growth	-0.42%	2.35%	4.71%	-0.01%	19.30%	13.37%
Gross Profit	761.25	757.67	685.25	584.05	648.04	579.27
Operating Income	243.39	215.42	184.63	160.64	158	140.63
Net Income	218.72	198.88	184.25	148.21	193.57	143.28
Earnings Per Share	0.39	0.35	0.33	0.26	0.35	0.26
EPS Growth	9.97%	7.94%	24.32%	-23.43%	35.09%	13.21%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	902.58	688.32	583.59	658.06	1,050	300.26
Total Debt	0.95	0.4	72.4	80.4	0.4	0.4
Net Cash (Debt)	901.63	687.92	511.19	577.66	1,049	299.86
Net Cash Growth	31.07%	34.57%	-11.51%	-44.95%	249.97%	5.90%
Net Cash Per Share	1.61	1.23	0.91	1.03	1.87	0.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	313.24	219.65	315.95	203.99	215.09
Capital Expenditures	-	-12.45	-11.02	-31.84	-11.32	-92.84
Free Cash Flow	-	300.8	208.63	284.11	192.68	122.26
Free Cash Flow Growth	-	44.18%	-26.57%	47.45%	57.60%	133.03%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	84.77%	84.01%	77.77%	69.40%	77.00%	82.11%
Operating Margin	27.10%	23.89%	20.95%	19.09%	18.77%	19.93%
Pretax Margin	32.48%	29.32%	23.51%	23.57%	23.45%	25.13%
Profit Margin	24.36%	22.05%	20.91%	17.61%	23.00%	20.31%
FCF Margin	-	33.35%	23.68%	33.76%	22.89%	17.33%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.20	5.52	3.94	5.63	2.23	3.76
P/FCF Ratio	-	3.65	3.48	2.94	2.24	4.41
PS Ratio	1.27	1.22	0.83	0.99	0.51	0.76